TY  - BOOK
U1  - Buch
ED  - Otte, Andreas
ED  - Erens, Oliver
T1  - Geschichte(n) der Medizin
N2  - Renommierte Autoren erzählen lebendige und mitreißende Geschichte(n) der Medizin über Krankheiten, Ärzte und Forscher.
-Wie kam es zur Entdeckung des Blutkreislaufes, wo man doch lange Zeit glaubte, die Leber produziere täglich Tausende von Litern Blut?
-Warum sind Hirnschrittmacher erst viel später als Herzschrittmacher auf der medizinischen Bühne erschienen, wo doch das Gehirn schon in der Antike trepaniert und erforscht wurde?
-Die Antworten auf diese und andere Fragen werden nicht nur wissenschaftlich exakt, sondern auch überaus unterhaltsam gegeben.
-Beachtlich, dass Friedrich II. von Preußen auch begnadeter Hobby-Arzt war.
-Bemerkenswert, wie eine Frau zu einer Zeit zielstrebig Ärztin wurde, als nur Männer Medizin studieren durften.
-Bewegend die Erlebnisse eines Arztes an der Front.
-Faszinierend, wie ein „Wunderdoktor“ reihenweise Frauen in Ohnmacht versetzte, um sie zu heilen; er wurde damit zum Mitbegründer der Psychotherapie.
-Das Buch knüpft mit diesen und weiteren Erzählungen an den großen Erfolg des ersten Bandes an und bietet in populärwissenschaftlicher Weise neues Lese- und Bildungsvergnügen.
KW  - Medizin
KW  - Erzählung
Y1  - 2015
SN  - 978-3-87247-770-5
SB  - 978-3-87247-770-5
VL  - 2
SP  - 174
S1  - 174
PB  - Alfons W. Gentner Verlag
CY  - Stuttgart
ET  - 1.
ER  - 
TY  - CHAP
U1  - Konferenzveröffentlichung
A1  - Ortega Clavero, Valentin
A1  - Weber, Andreas
A1  - Schröder, Werner
A1  - Curticapean, Dan
T1  - Potential use of the characteristic Raman lines of toluene (C7H8 ) as a reference on the spectral analysis of fuel blends
T2  - Proceedings of SPIE: Optical Measurement Systems for Industrial Inspection IX
N2  - We report the use of the Raman spectral information of the chemical compound toluene C7H8 as a reference on the analysis of laboratory-prepared and commercially acquired gasoline-ethanol blends. The rate behavior of the characteristic Raman lines of toluene and gasoline has enabled the approximated quantification of this additive in commercial gasoline-ethanol mixtures. This rate behavior has been obtained from the Raman spectra of gasoline-ethanol blends with different proportions of toluene.

All these Raman spectra have been collected by using a self-designed, frequency precise and low-cost Fourier-transform Raman spectrometer (FT-Raman spectrometer) prototype. This FT-Raman prototype has helped to accurately confirm the frequency position of the main characteristic Raman lines of toluene present on the different gasoline-ethanol samples analyzed at smaller proportions than those commonly found in commercial gasoline-ethanol blends. The frequency accuracy validation has been performed by analyzing the same set of toluene samples with two additional state-of-the-art commercial FT-Raman devices. Additionally, the spectral information has been contrasted, with highly-correlated coefficients as a result, with the values of the standard Raman spectrum of toluene.
KW  - Raman-Spektroskopie
KW  - Spektralanalyse
Y1  - 2015
SN  - 0277-786X
SS  - 0277-786X
SN  - 9781628416855
SB  - 9781628416855
U6  - https://dx.doi.org/10.1117/12.2185100
DO  - https://dx.doi.org/10.1117/12.2185100
N1  - Konferenz: SPIE Optical Metrology, 2015, Munich, Germany
VL  - 9525
SP  - 95254G
S1  - 7
CY  - München
ER  - 
TY  - JOUR
U1  - Zeitschriftenartikel, wissenschaftlich - begutachtet (reviewed)
A1  - Riemann, Dieter
A1  - Nissen, Christoph
A1  - Palagini, Laura
A1  - Otte, Andreas
A1  - Perlis, Michael L.
A1  - Spiegelhalder, Kai
T1  - The neurobiology, investigation, and treatment of chronic insomnia
JF  - The Lancet Neurology
N2  - Chronic insomnia is defined by difficulties in falling asleep, maintaining sleep, and early morning awakening, and is coupled with daytime consequences such as fatigue, attention deficits, and mood instability. These symptoms persist over a period of at least 3 months (Diagnostic and Statistical Manual 5 criteria). Chronic insomnia can be a symptom of many medical, neurological, and mental disorders. As a disorder, it incurs substantial health-care and occupational costs, and poses substantial risks for the development of cardiovascular and mental disorders, including cognitive deficits. Family and twin studies confirm that chronic insomnia can have a genetic component (heritability coefficients between 42% and 57%), whereas the investigation of autonomous and central nervous system parameters has identified hyperarousal as a final common pathway of the pathophysiology, implicating an imbalance of sleep–wake regulation consisting of either overactivity of the arousal systems, hypoactivity of the sleep-inducing systems, or both. Insomnia treatments include benzodiazepines, benzodiazepine-receptor agonists, and cognitive behavioural therapy. Treatments currently under investigation include transcranial magnetic or electrical brain stimulation, and novel methods to deliver psychological interventions.
KW  - Schlafstörung
Y1  - 2015
SN  - 1474-4422
SS  - 1474-4422
U6  - https://dx.doi.org/10.1016/S1474-4422(15)00021-6
DO  - https://dx.doi.org/10.1016/S1474-4422(15)00021-6
VL  - 14
IS  - 5
SP  - 547
EP  - 558
PB  - Elsevier
ER  -